Madrigal PharmaceuticalsMDGL
那斯達克 · USD
447.09
-2.65
(-0.59%)
收盤 10/20 03:59 (UTC+8)
盤後
446.00
446.00
(-0.24%)
10/20 03:59 (UTC+8)
Madrigal PharmaceuticalsMDGL
447.09
-2.65
(-0.59%)
財務數據
損益表
- -
- 0.15
- 0.62
- 1.03
- 1.37
- 2.13
- 2.87
- 3.21
- 3.11
- 3.64
- -
- -
- 324.75
- 66.18
- 32.84
- 55.05
- 34.99
- 11.77
- -3.04
- 17.00
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 364,252 | 311,337 | 321,083 | 287,268 | 212,802 | 137,250 | 103,320 | 62,175 | 14,638 | - |
營業成本 | 40,007 | 26,847 | 24,448 | 18,122 | 9,065 | 4,513 | 3,445 | 2,152 | 636 | - |
營業毛利 | 324,245 | 284,490 | 296,635 | 269,146 | 203,737 | 132,737 | 99,875 | 60,023 | 14,002 | - |
營業費用 | 380,553 | 377,213 | 356,244 | 383,121 | 250,939 | - | - | - | - | 152,037 |
研發費用 | 91,178 | 108,692 | 116,268 | 174,004 | 54,081 | 44,172 | 25,648 | 68,742 | 71,091 | 71,237 |
推銷及管理費用 | 289,375 | 268,521 | 239,976 | 209,117 | 196,858 | 167,876 | 141,223 | 107,585 | 105,449 | 80,800 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -56,308 | -92,723 | -59,609 | -113,975 | -47,202 | -79,311 | -66,996 | -116,304 | -162,538 | -152,037 |
其他收入及費用 | 6,309 | 6,151 | 9,331 | 7,236 | 8,185 | 9,370 | 11,079 | 13,019 | 14,222 | 8,334 |
利息費用 | 7,940 | 7,819 | 8,297 | 7,451 | 3,264 | 3,297 | 3,499 | 3,679 | 3,655 | 3,838 |
稅前純益 | -57,939 | -94,391 | -58,575 | -114,190 | -42,281 | -73,238 | -59,416 | -106,964 | -151,971 | -147,541 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -57,939 | -94,391 | -58,575 | -114,190 | -42,281 | -73,238 | -59,416 | -106,964 | -151,971 | -147,541 |
基本每股稅後盈餘(元) | -1.99 | -3.25 | -2.57 | -5.08 | -1.50 | -2.61 | -2.71 | -4.92 | -7.10 | -7.38 |
稀釋每股稅後盈餘(元) | -1.99 | -3.25 | -2.53 | -6.22 | -1.49 | -2.61 | -2.59 | -4.84 | -7.09 | -7.38 |
基本平均股數(千股) | 29145.00 | 29032.00 | 22829.00 | 22482.00 | 28232.00 | 28085.00 | 21929.00 | 21745.00 | 21402.00 | 20001.00 |
稀釋平均股數(千股) | 29145.00 | 29032.00 | 22829.00 | 22482.00 | 28232.00 | 28085.00 | 21929.00 | 21745.00 | 21402.00 | 20001.00 |
還原基本每股稅後盈餘(元) | -1.99 | -3.25 | -2.57 | -5.08 | -1.50 | -2.61 | -2.71 | -4.92 | -7.10 | -7.38 |
還原稀釋每股稅後盈餘(元) | -1.99 | -3.25 | -2.53 | -6.22 | -1.49 | -2.61 | -2.59 | -4.84 | -7.09 | -7.38 |
還原基本平均股數(千股) | 29,145 | 29,032 | 22,829 | 22,482 | 28,232 | 28,085 | 21,929 | 21,745 | 21,402 | 20,001 |
還原稀釋平均股數(千股) | 29,145 | 29,032 | 22,829 | 22,482 | 28,232 | 28,085 | 21,929 | 21,745 | 21,402 | 20,001 |
EBITDA(千元) | -48,509 | -85,329 | -47,870 | -104,501 | -38,214 | -69,070 | -55,014 | -102,965 | -147,577 | -142,880 |